Ayursatva Herbals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.35 M
as on 12-12-2024
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 15.59%
(FY 2019)
- Profit -50.06%
(FY 2019)
- Ebitda -31.13%
(FY 2019)
- Net Worth 15.40%
(FY 2019)
- Total Assets -0.92%
(FY 2019)
About Ayursatva Herbals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.35 M, as per Ministry of Corporate Affairs (MCA) records.
Vijay Jethani, Cherian Koshy, Pramod Waikar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24233MP2008PTC020206
- Company No.
020206
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ayursatva Herbals Private Limited offer?
Ayursatva Herbals Private Limited offers a wide range of products and services, including Tea & Coffee, Herbal Tea.
Who are the key members and board of directors at Ayursatva Herbals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Jethani  | Director | 15-Jan-2008 | Current |
| Cherian Koshy | Director | 15-Jan-2008 | Current |
| Pramod Waikar | Director | 15-Jan-2008 | Current |
| Achyut Padmawar | Director | 15-Jan-2008 | Current |
| Rajesh Ramanujacharya | Director | 15-Jan-2008 | Current |
Financial Performance of Ayursatva Herbals.
Ayursatva Herbals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 15.59% increase. The company also saw a substantial fall in profitability, with a 50.06% decrease in profit. The company's net worth Soared by an impressive increase of 15.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ayursatva Herbals?
In 2019, Ayursatva Herbals had a promoter holding of 85.71% and a public holding of 14.29%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Amruta Herbals Private LimitedActive 19 years 4 monthsVijay Jethani, Cherian Koshy and 3 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ayursatva Herbals?
Unlock and access historical data on people associated with Ayursatva Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ayursatva Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ayursatva Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
